Le Lézard
Classified in: Health, Science and technology, Business
Subject: PER

Eliassen Group Appoints New Leadership to Expand Expertise

READING, Mass., June 28, 2022 /PRNewswire/ -- Eliassen Group, a strategic consulting company, announced today the appointment of individuals to several crucial roles: Eleanore Doyle as President, Global Head of Life Sciences and Doug Nelson as Chief Financial Officer. The company has also announced the promotion of Tom Hart to the position of President ? Talent Solutions and Scott Cordeiro as President ? Professional Services. These updates will enhance our Executive Leadership team that propels our company forward.

As President, Global Head of Life Sciences for a company of Eliassen Group ? EG Life Sciences, Eleanore will be charged with leading Operational oversight and overall growth and capabilities, actively working with our consulting and talent solution verticals to deliver enterprise-integrated solutions. She has more than 30 years of industry experience in both Life Science and IT industries, and she spent 18 years in the Contract Research Organization (CRO) industry, where she led global Functional Service Provider (FSP) strategy and delivery.

Doug will oversee Eliassen Group's financial strategy as the company continues to scale its operations to drive profitable growth and support major initiatives. Prior to joining Eliassen, Doug Nelson served as the Vice President of Finance and Accounting at a tech-enabled roadside assistance company focused on the OEM and Auto Insurance industries. Prior to that, Doug held senior finance leadership positions for retail and healthcare companies.

Since joining Eliassen Group in 2012, Tom Hart has overseen talent solutions for regional organizations. Previously, Tom served as the executive vice president for client management, commercial consulting, talent acquisition, operations management, and information technology for a strategic human resources company within the financial space.

Scott Cordeiro joined the company in 2009, and since then he has overseen the growth of professional services, where he is charged with driving overall growth and capabilities, actively managing executive relationships, providing field support to leadership, and integrating new professional services capabilities in business and technology.

"It's incredible to see some of our exceptional leaders rise to take on increased responsibility in the company, and we're equally thrilled to welcome incredible new talent to our team," said Eliassen Group CEO Dave MacKeen. "All four of these folks personally impact and enhance the experience for our clients, and they will guide both Eliassen Group and EG Life Sciences to new heights."

About Eliassen Group

Eliassen Group is a leading strategic consulting company that provides business and IT services for our clients as they seek to transform and execute strategies that will drive exceptional outcomes. Leveraging over 30 years of success, we focus on professional services, talent solutions, and life sciences. Eliassen Group offers local community presence and deep networks. We are committed to positively impacting the lives of our employees, clients, consultants, and the communities in which we operate.

About EG Life Sciences

EG Life Sciences, a company of Eliassen Group, delivers scalable solutions to medical device, pharmaceutical, biometrics, and diagnostics organizations, including the resources they need to meet the unique challenges of FDA regulations and submissions. When partnering with EG Life Sciences, our clients are connected with elevated subject matter experts who hit the ground running, working to produce high-level results that are strategically delivered on time and within budget. We have a genuine dedication to the people we serve and understand that peak performance saves lives.

Media Contact
Sandra G. Callahan
SVP| Head of Marketing| Brand| Communications
Eliassen Group
781 205 8148


SOURCE Eliassen Group

These press releases may also interest you

at 17:53
HAVN Life Sciences Inc.  (the "Company" or "HAVN Life") a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce that it has closed the initial tranche...

at 17:47
Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, today announced that results from the Phase 3 BEACON study in Retinal...

at 17:34
The Registered Nurses' Association of Ontario (RNAO) says the government's five-point plan to tackle health system challenges represents an important building block to begin tackling critical issues facing the nursing profession. It should be...

at 17:00
Shaklee, a leading wellness company, announces today it has reached more than 133,000 at-risk children through its partnership with Vitamin Angels. With every Meology Kids all-in-one vitamin gummy pack sold, Shaklee provides essential nutrients and...

at 16:55
Henry Schein, Inc. , the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the publication of its 2021 Sustainability and Corporate Social Responsibility (CSR) Report, titled "BOLD...

at 16:55
Schrödinger, Inc. , whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced the grant of inducement equity awards to the company's newly appointed chief financial officer, Geoffrey...

News published on 28 june 2022 at 07:33 and distributed by: